Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Riggs

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Journal of Clinical Epidemiology|December 1, 1994
Age-specific mortality rate comparisons: is there a fallacy?J E Riggs
Journal of Clinical Epidemiology|November 1, 1993
Stone-age genes and modern lifestyle: evolutionary mismatch or differential survival biasJ E Riggs
Archives of Neurology|August 1, 1988
The evolving natural history of neurologic involvement in Whipple disease: a hypothesisJ E Riggs
Neurologic Clinics|July 17, 1998
Aging, increasing genomic entropy, and neurodegenerative diseaseJ E Riggs
Mechanisms of Ageing and Development|December 2, 1991
Longitudinal Gompertzian analysis of pancreatic cancer mortality in the U.S., 1962-1987: distinguishing between competitive and environmental influences upon evolving mortality patternsJ E Riggs
Mechanisms of Ageing and Development|April 1, 1992
Longitudinal Gompertzian analysis of cervical cancer mortality in the US, 1962-1987: a method of quantitatively demonstrating changing environmental influences upon deterministic mortality dynamicsJ E Riggs
Mechanisms of Ageing and Development|November 1, 1991
Longitudinal Gompertzian analysis of primary malignant brain tumor mortality in the U.S., 1962-1987: rising mortality in the elderly is the natural consequence of competitive deterministic dynamicsJ E Riggs
Lancet (London, England)|March 18, 1995
Preference, paradox, and health care reformJ E Riggs
Mechanisms of Ageing and Development|January 1, 1991
Longitudinal Gompertzian analysis of ischemic heart disease mortality in the U.S., 1962-1986: a method of demonstrating the deterministic dynamics describing its declineJ E Riggs
Clinical Neuropharmacology|December 1, 1991
Parkinson's disease: an epidemiologic method for distinguishing between symptomatic and neuroprotective treatmentsJ E Riggs
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Epidemiology|December 1, 1994
Age-specific mortality rate comparisons: is there a fallacy?J E Riggs
Journal of Clinical Epidemiology|November 1, 1993
Stone-age genes and modern lifestyle: evolutionary mismatch or differential survival biasJ E Riggs
Archives of Neurology|August 1, 1988
The evolving natural history of neurologic involvement in Whipple disease: a hypothesisJ E Riggs
Neurologic Clinics|July 17, 1998
Aging, increasing genomic entropy, and neurodegenerative diseaseJ E Riggs
Mechanisms of Ageing and Development|December 2, 1991
Longitudinal Gompertzian analysis of pancreatic cancer mortality in the U.S., 1962-1987: distinguishing between competitive and environmental influences upon evolving mortality patternsJ E Riggs
Mechanisms of Ageing and Development|April 1, 1992
Longitudinal Gompertzian analysis of cervical cancer mortality in the US, 1962-1987: a method of quantitatively demonstrating changing environmental influences upon deterministic mortality dynamicsJ E Riggs
Mechanisms of Ageing and Development|November 1, 1991
Longitudinal Gompertzian analysis of primary malignant brain tumor mortality in the U.S., 1962-1987: rising mortality in the elderly is the natural consequence of competitive deterministic dynamicsJ E Riggs
Lancet (London, England)|March 18, 1995
Preference, paradox, and health care reformJ E Riggs
Mechanisms of Ageing and Development|January 1, 1991
Longitudinal Gompertzian analysis of ischemic heart disease mortality in the U.S., 1962-1986: a method of demonstrating the deterministic dynamics describing its declineJ E Riggs
Clinical Neuropharmacology|December 1, 1991
Parkinson's disease: an epidemiologic method for distinguishing between symptomatic and neuroprotective treatmentsJ E Riggs
Pageof 21